Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial Proceeding/Conference:Journal of Hepatology | 2019 | |||
2018 | 58 | |||
Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B Proceeding/Conference:Journal of Hepatology | 2018 | 44 | ||
Inarigivir: a novel RIG-I agonist for chronic hepatitis B Proceeding/Conference:Hepatology International | 2018 |